[A case of metronidazole-induced encephalopathy that is difficult to differentiate from Wernicke encephalopathy]

Takayuki Konishi1, Junichi Uemura2, Shinji Yamashita2

  • 1Department of Internal Medicine, Kawasaki Medical School, General Medical Center.

Insights

A patient developed neurological symptoms including ataxia and dysarthria after metronidazole treatment for an iliopsoas abscess. The symptoms resolved after discontinuing the antibiotic, confirming metronidazole-induced encephalopathy.

Area of Science:

  • Neurology
  • Toxicology

Background:

  • Metronidazole is an antibiotic commonly used to treat anaerobic bacterial infections.
  • Neurological side effects, though rare, can occur with metronidazole use.

Observation:

  • A 76-year-old male presented with dysarthria, nystagmus, and cerebellar ataxia following metronidazole treatment for an iliopsoas abscess.
  • Head MRI revealed symmetrical hyperintensities in the cerebellum, midbrain, and corpus callosum.

Findings:

  • The patient's symptoms and MRI findings mimicked Wernicke's encephalopathy.
  • Normal thiamine levels and rapid symptom improvement after metronidazole cessation confirmed metronidazole-induced encephalopathy.

Implications:

  • Metronidazole-induced encephalopathy should be considered in patients presenting with these neurological symptoms, especially when midbrain red nucleus lesions are present.
  • Distinguishing metronidazole-induced encephalopathy from Wernicke's encephalopathy is crucial for appropriate management and treatment.
  • This case highlights the importance of considering drug toxicity in the differential diagnosis of encephalopathy.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
150
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
301
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110